Ruth Coleman

Ruth Coleman

Venture Capital Investor @ Mercia Ventures | Healthtech, Life Sciences & Software

I specialize in

Fundraising 101
VC & Angel Advice
Idea to Launch
Fundraising strategy
Growth
Positioning
Pitch feedback
Story & narrative

I back ambitious founders building great companies!

Background & Highlights

Mercia Ventures has c.1 Bn AUM. We are one the most active early stage investors in the UK investing £1 -10 M across Seed and Series A.

Mercia Ventures

2022 – Present

Mercia Ventures

Board Member of several startups

Laverock Therapeutics

2023 – Present

Laverock Therapeutics

About me

Seed to Series B founders building healthcare, life sciences, or software companies who are navigating fundraising, product strategy, and early-stage growth. I’m a venture capital investor at Mercia Ventures, focused on supporting founders from Seed through Series B across healthtech, life sciences, and software. My background combines investing with hands-on operating experience, giving me perspective on both building companies and backing them. Before venture, I worked at HealthXL, a global health innovation platform that was later acquired, and at Grey Innovation, where I helped venture build new companies and technologies. I also come from a biomedical science background, which gives me a strong foundation for evaluating scientific and healthcare innovation alongside commercial opportunity. I enjoy working closely with founders navigating the challenges of early growth, fundraising, and translating complex ideas into scalable businesses. If you’re building in healthtech, life sciences, or software and want thoughtful perspective on growth, fundraising, or strategy, I’d love to connect on Hubble.

You'll get advice on

  • Healthtech & Life Sciences Innovation
  • Early-Stage Growth & Scaling
  • Raising Venture
  • Product & Commercial Positioning
  • Navigating Seed to Series B

Real feedback from real sessions

Meet more experts on this topic